Macrogenics Stock Technical Analysis

MGNX Stock  USD 1.93  0.13  7.22%   
As of the 30th of January, MacroGenics secures the Downside Deviation of 3.93, risk adjusted performance of 0.0356, and Mean Deviation of 3.2. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MacroGenics, as well as the relationship between them.

MacroGenics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as MacroGenics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MacroGenicsMacroGenics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

MacroGenics Analyst Consensus

Target PriceAdvice# of Analysts
3.4Buy9Odds
MacroGenics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most MacroGenics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MacroGenics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MacroGenics, talking to its executives and customers, or listening to MacroGenics conference calls.
MacroGenics Analyst Advice Details
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MacroGenics. Expected growth trajectory for MacroGenics significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MacroGenics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.21)
Revenue Per Share
2.025
Quarterly Revenue Growth
(0.34)
Return On Assets
(0.27)
Understanding MacroGenics requires distinguishing between market price and book value, where the latter reflects MacroGenics's accounting equity. The concept of intrinsic value—what MacroGenics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push MacroGenics' price substantially above or below its fundamental value.
Understanding that MacroGenics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MacroGenics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MacroGenics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

MacroGenics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MacroGenics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MacroGenics.
0.00
11/01/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/30/2026
0.00
If you would invest  0.00  in MacroGenics on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding MacroGenics or generate 0.0% return on investment in MacroGenics over 90 days. MacroGenics is related to or competes with Ovid Therapeutics, Context Therapeutics, Clene, Whitehawk Therapeutics, Shattuck Labs, Connect Biopharma, and Oramed Pharmaceuticals. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer ... More

MacroGenics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MacroGenics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MacroGenics upside and downside potential and time the market with a certain degree of confidence.

MacroGenics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for MacroGenics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MacroGenics' standard deviation. In reality, there are many statistical measures that can use MacroGenics historical prices to predict the future MacroGenics' volatility.
Hype
Prediction
LowEstimatedHigh
0.101.946.26
Details
Intrinsic
Valuation
LowRealHigh
0.122.456.77
Details
Naive
Forecast
LowNextHigh
0.041.906.22
Details
9 Analysts
Consensus
LowTargetHigh
3.093.403.77
Details

MacroGenics January 30, 2026 Technical Indicators

MacroGenics Backtested Returns

MacroGenics appears to be very risky, given 3 months investment horizon. MacroGenics has Sharpe Ratio of 0.0978, which conveys that the firm had a 0.0978 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for MacroGenics, which you can use to evaluate the volatility of the firm. Please exercise MacroGenics' Risk Adjusted Performance of 0.0356, downside deviation of 3.93, and Mean Deviation of 3.2 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MacroGenics holds a performance score of 7. The company secures a Beta (Market Risk) of 0.43, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MacroGenics' returns are expected to increase less than the market. However, during the bear market, the loss of holding MacroGenics is expected to be smaller as well. Please check MacroGenics' downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether MacroGenics' current price movements will revert.

Auto-correlation

    
  -0.48  

Modest reverse predictability

MacroGenics has modest reverse predictability. Overlapping area represents the amount of predictability between MacroGenics time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MacroGenics price movement. The serial correlation of -0.48 indicates that about 48.0% of current MacroGenics price fluctuation can be explain by its past prices.
Correlation Coefficient-0.48
Spearman Rank Test-0.51
Residual Average0.0
Price Variance0.01
MacroGenics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of MacroGenics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MacroGenics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

MacroGenics Technical Analysis

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of MacroGenics volatility developed by Welles Wilder.

About MacroGenics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of MacroGenics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of MacroGenics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on MacroGenics price pattern first instead of the macroeconomic environment surrounding MacroGenics. By analyzing MacroGenics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of MacroGenics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to MacroGenics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2025 2026 (projected)
Payables Turnover1.282.212.32
Days Of Inventory On Hand54.262.3359.22

MacroGenics January 30, 2026 Technical Indicators

Most technical analysis of MacroGenics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for MacroGenics from various momentum indicators to cycle indicators. When you analyze MacroGenics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

MacroGenics January 30, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as MacroGenics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.